XYLT1 Antibody

Code CSB-PA026241GA01HU
Size $600
Order now
Have Questions? Leave a Message or Start an on-line Chat

Product Details

Uniprot No.
Target Names
XYLT1
Alternative Names
Beta D xylosyltransferase 1 antibody; O xylosyltransferase 1 antibody; Peptide O-xylosyltransferase 1 antibody; PXYLT1 antibody; UDP-D-xylose:proteoglycan core protein antibody; XT-I antibody; XT1 antibody; XTI antibody; Xylosyltransferase 1 antibody; Xylosyltransferase I antibody; xylosyltransferase iota antibody; XylT-I antibody; XYLT1 antibody; XYLT1_HUMAN antibody
Raised in
Rabbit
Species Reactivity
Human,Mouse,Rat
Immunogen
Human XYLT1
Immunogen Species
Homo sapiens (Human)
Isotype
IgG
Purification Method
Antigen Affinity purified
Concentration
It differs from different batches. Please contact us to confirm it.
Buffer
0.1M NaHCO3,0.1M Glycine, 0.02% Sodium Azide, 50% Glycerol, pH 7.3. -20°C, Avoid freeze / thaw cycles.
Tested Applications
ELISA,WB
Troubleshooting and FAQs
Storage
Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Lead Time
Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.

Customer Reviews and Q&A

 Customer Reviews

There are currently no reviews for this product.

Submit a Review here

Target Background

Function
Catalyzes the first step in the biosynthesis of chondroitin sulfate and dermatan sulfate proteoglycans, such as DCN. Transfers D-xylose from UDP-D-xylose to specific serine residues of the core protein. Required for normal embryonic and postnatal skeleton development, especially of the long bones. Required for normal maturation of chondrocytes during bone development, and normal onset of ossification.
Gene References into Functions
  1. In conclusion, we identified two genes, DZIP1 and XYLT1, potentially associated with nonsyndromic high myopia using whole exome sequencing and subsequent mutation screening analysis. PMID: 28085539
  2. Novel and recurrent XYLT1 mutations in two Turkish families with Desbuquois dysplasia, type 2, have been reported. PMID: 27881841
  3. Our study describes the first case of DBQD2 resulting from compound heterozygous XYLT1 mutation, expands the mutational spectrum of the disease and provides evidence that the severe growth retardation and microsomia observed in DBQD2 patients may result not only from the skeletal dysplasia itself but also from GH and IGF-1 deficiency. PMID: 27030147
  4. XYLT1 mutation is associated with short limb skeletal dysplasia. PMID: 26601923
  5. Human XYLT1 promoter sequence analysis and description. PMID: 25480529
  6. These results suggest that XT-1 expression is refractory to the disease process and to inhibition by inflammatory cytokines and that signaling through AP-1, Sp1, and Sp3 is important in the maintenance of XT-1 levels in NP cells. PMID: 25476526
  7. five distinct homozygous XYLT1 mutations may have a role in Desbuquois dysplasia type 2 PMID: 24581741
  8. A family study shows that functional alterations of XYLT1 cause an autosomal recessive short stature syndrome associated with intellectual disability. PMID: 23982343
  9. XYLT1 activity increased time-dependently in response to progressive myofibroblast transformation. PMID: 23747722
  10. AP-1 and Sp3 are key regulators of IL-1beta-mediated modulation of xylosyltransferase I expression. PMID: 23223231
  11. Xylosyltransferase-I regulates glycosaminoglycan synthesis during the pathogenic process of human osteoarthritis PMID: 22479506
  12. DXD motifs in human xylosyltransferase I are required for enzyme activity PMID: 15294915
  13. Elevated XYLT1 activities in pseudoxanthoma elasticum patients is a marker of proteoglycan biosynthesis. PMID: 16133423
  14. xylotransferase genes might be potential candidate genes predisposing to diabetic nephropathy in type 1 diabetic patients PMID: 16164625
  15. Over 80% of the nucleotide sequence of the XT-I-cDNA is necessary for expressing a recombinant enzyme with full catalytic activity. PMID: 16225459
  16. recombinant expression and cloning of active full-length xylosyltransferase I (XT-I) and characterization of subcellular localization of XT-I and XT-II PMID: 16569644
  17. Variations in the XYLT-II gene are genetic co-factors in the severity of PXE. PMID: 16571645
  18. Increased levels of xylosyltransferase I correlates with the formation of extracellular matrix during chondrogenic differentiation of mesenchymal stem cells. PMID: 16778156
  19. The XYLT-I c.343G>T polymorphism contributes to the genetic susceptibility to development of diabetic nephropathy in type 1 diabetic patients. PMID: 17003309
  20. TGF-beta(1) and mechanical stress induce xylosyltransferase I expression in cardiac fibroblasts and have impact for ECM remodeling in the dilated heart. PMID: 17635914
  21. For the rate-limiting enzyme in glycosaminoglycan synthesis XT-I, maximal mRNA expression and enzyme activity were observed 10 days after osteogenic induction of mesenchymal stem cells, simultaneously to the beginning of ECM mineralization. PMID: 17980567
  22. results show that XT-I polymorphisms potentially confer to the genetic susceptibility of abdominal aortic aneurysm PMID: 18294457
  23. These results point to skeletal growth and tissue remodeling as a cause of the high XT activity in children PMID: 18763033
  24. Data show that the xylosyltransferase I SNP is associated with a decreased glycosaminoglycan amount in the serum of healthy blood donors. PMID: 19014925
  25. No statistically significant association was found between four XYLT variants and hypertension or blood pressure, suggesting that they do not play a significant role in the development of essential hypertension. PMID: 19197251
  26. AP-1 Sp1 family of transcription factors are necessary for the transcriptional regulation of the XYLT1 gene. PMID: 19762916

Show More

Hide All

Involvement in disease
Desbuquois dysplasia 2 (DBQD2); Pseudoxanthoma elasticum (PXE)
Subcellular Location
Golgi apparatus membrane; Single-pass type II membrane protein. Secreted.
Protein Families
Glycosyltransferase 14 family, XylT subfamily
Tissue Specificity
Widely expressed. Expressed at higher level in placenta, kidney and pancreas. Weakly expressed in skeletal muscle.
Database Links

HGNC: 15516

OMIM: 264800

KEGG: hsa:64131

STRING: 9606.ENSP00000261381

UniGene: Hs.22907

icon of phone
Call us
301-363-4651 (Available 9 a.m. to 5 p.m. CST from Monday to Friday)
icon of address
Address
7505 Fannin St., Ste 610, Room 7 (CUBIO Innovation Center), Houston, TX 77054, USA
icon of social media
Join us with

Subscribe newsletter

Leave a message

* To protect against spam, please pass the CAPTCHA test below.
CAPTCHA verification
© 2007-2024 CUSABIO TECHNOLOGY LLC All rights reserved. 鄂ICP备15011166号-1
Place an order now

I. Product details

*
*
*
*

II. Contact details

*
*

III. Ship To

*
*
*
*
*
*
*

IV. Bill To

*
*
*
*
*
*
*
*